Early costs and complications of first-line low-grade glioma treatment using a large national database: Limitations and future perspectives

IntroductionDiffuse Low-grade gliomas (DLGG, WHO Grade II) are a heterogenous group of tumors comprising 13–16% of glial tumors. While maximal safe resection is endorsed as the best approach to DLGG, compared to more conservative interventions like stereotactic biopsy, the added costs and risks have...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Kyle Tuohy, Djibril M. Ba, Debarati Bhanja, Douglas Leslie, Guodong Liu, Alireza Mansouri
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Frontiers Media S.A. 2023-02-01
Schriftenreihe:	Frontiers in Surgery
Schlagworte:	low-grade glioma (WHO grade II) cost resection stereotactic biopsy adverse events—complications MarketScan database
Online-Zugang:	https://www.frontiersin.org/articles/10.3389/fsurg.2023.1001741/full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!